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Background: The potential use of quantum dots (QD) in biomedical applications, as well as in other systems that
take advantage of their unique physiochemical properties, has led to concern regarding their toxicity, potential
systemic distribution, and biopersistence. In addition, little is known about workplace exposure to QD in research,
manufacturing, or medical settings. The goal of the present study was to assess pulmonary toxicity, clearance, and
biodistribution of QD with different functional groups in rats after pulmonary exposure.
Methods: QD were composed of a cadmium-selenide (CdSe) core (~5nm) with a zinc sulfide (ZnS) shell
functionalized with carboxyl (QD-COOH) or amine (QD-NH2) terminal groups. Male Sprague–Dawley rats were
intratracheally-instilled (IT) with saline, QD-COOH, or QD-NH2 (12.5, 5.0, or 1.25 μg/rat). On days 0, 1, 3, 5, 7, 14, and
28 post-IT, the left lung, lung-associated lymph nodes (LALN), heart, kidneys, spleen, liver, brain, and blood were
collected for metal analysis of Cd content by neutron activation to evaluate clearance and biodistribution. One right
lobe was ligated and fixed for microscopy and histopathological analysis. The remaining right lobes from rats in
each group were subjected to bronchoalveolar lavage (BAL) to retrieve BAL fluid and cells for analysis of injury and
inflammation.
Results: Lung injury and inflammation was found to be dose-dependent and peaked at days 7 and 14 post-exposure
for both forms of QD, with slight variations in degree of toxicity at early and later time points. Both QD appeared to
lose their fluorescent properties and destabilize after 1 week in the lung. Cd persisted up to 28 days for both forms of
QD; however, clearance rate was slightly greater for QD-COOH over time. No Cd was detected in the liver, spleen, heart,
brain, or blood at any time point. Cd appeared in the LALN and kidneys beginning at 1–2 weeks post-exposure.
Conclusions: QD-COOH and QD-NH2 differed in clearance rate and differed slightly in degree of toxicity at different
time points; however, the overall pattern of toxicity and biodistribution was similar between the two particles. Toxicity
may be dependent on the dissolution rate and bioavailability of free Cd.
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Quantum dots (QD), also referred to as nanocrystals, are
fluorescent semiconductor nanomaterials (~2-100 nm in
diameter) commonly used in the biomedical and electronic
industries [1,2]. In terms of structure, QD are nanocrystals
composed of a semiconductor core [e.g., cadmium-selenide
(CdSe)] encased within a shell comprised of a second semi-
conductor material [e.g., zinc sulfide (ZnS)] [3]. Due to their
small size, QD have unique optical and electronic proper-
ties that impart the nanoparticle with a bright, high inten-
sity fluorescence [4], which persists as long the QD remain
stable. The emission wavelength of the QD is specific to the
size and composition of the nXanocrystal, where increasing
size results in increasing emission wavelength. Because of
their large surface area, QD are readily functionalized with
targeting ligands for site-directed activity. Biomedical ap-
plications exploit the fluorescent properties of QD for diag-
nostic tools (e.g., imaging), therapeutic purposes (e.g., drug
delivery and cancer treatment), live cell labeling, and track-
ing over long periods of time [2]. QD are also being incor-
porated into solar cell and electronic devices, such as
LEDs, where their electronic and optical properties provide
advantages.
Due to the presence of Cd, a highly reactive and po-
tentially toxic metal, there is concern about the health
risks associated with exposure to QD. In vitro studies in-
dicate that some QD are cytotoxic in short-term, cell
culture-based assays (as reviewed by [1,3]). QD compos-
ition, size, charge, exposure concentration, outer coating
bioactivity (e.g., treatment with functional groups) and
oxidative properties, and mechanical stability have been
implicated as possible causative factors in the cytotox-
icity of QD [1]. Potential conditions of exposure to QD
include therapeutic, diagnostic, environmental, and oc-
cupational [1]. Workplace QD exposures (e.g., engineers,
researchers, clinicians) may result from inhalation, inges-
tion, and dermal contact.
Concerning inhalation, numerous animal studies have
examined the toxicology of other nanoparticles after pul-
monary exposure [5–9]; however, little is known about the
lung toxicity of QD. Ma-Hock et al. [10] performed a
short-term (6 hr/day for 5 days) inhalation study in which
Wistar rats were exposed to 4.1 mg/m3 (0.52 mg Cd/m3)
of a liquid aerosol of Cd-based QD (cadmium sulfide core
with a cadmium hydroxyl shell). A local inflammatory
response was observed at 8 days after exposure that re-
gressed after a 3-week recovery period with limited trans-
location of Cd from the lungs to systemic organs. In
addition, QD were observed within phagolysosomes of al-
veolar macrophages (AM) after inhalation exposure. Clift
et al. [11,12] demonstrated that QD, functionalized with
an organic coating or COOH or NH2 (PEG) (polyethylene
glycol) moieties, can cause oxidative stress, leading to
modulated Ca2+ signaling in a macrophage cell line afterprolonged in vitro exposure to sub-lethal concentrations,
and that toxicity is largely dependent on surface coating.
The goal of the current study was to expand upon the
limited information that is known about the in vivo effects
after pulmonary exposure to QD. Pulmonary toxicity and
lung distribution, clearance, and translocation of QD func-
tionalized with different surface moieties, resulting in
different surface charges, were examined. Commercially-
available QD, composed of a CdSe (~5 nm diameter) core
with a ZnS shell, were used. The QD were functionalized
with either amine (QD-NH2) or carboxyl (QD-COOH)
groups to form positively- or negatively-charged QD, re-
spectively. Rats were intratracheally instilled with various
doses of QD-NH2, QD-COOH, or phosphate-buffered
saline (PBS; vehicle control). Lung injury and inflamma-
tion were measured at 2 hr and at 1, 3, 5, 7, 14, and 28
days post-exposure. Sites of particle deposition and distri-
bution in the lungs and particle uptake by macrophages
were assessed using autometallographic silver enhance-
ment of QD in tissue, laser scanning confocal microscopy
(LSCM), and transmission electron microscopy (TEM).
Particle translocation from the lung was evaluated using
neutron activation analysis of Cd in lungs, blood, heart,
lung-associated lymph nodes (LALN), brain, kidneys, liver,
and spleen.
Results
Electron microscopy and EDX were performed to deter-
mine particle size and chemical composition of the QD
samples (Figure 1). TEM and FESEM confirmed that the
core size of the QD was ~5-10 nm in diameter (Figure 1A,
B, D, & E). EDX results show that QD-COOH and QD-
NH2 have similar metal constituents: Cd, Se, Zn, and S
(Figure 1C & F). There was an additional peak in the EDX
of the QD-NH2 sample indicating the presence of phos-
phorous (P). Hydrodynamic diameter was reported by the
manufacturer to be ~25 nm. Dynamic light scatterer
(DLS) measurements of the particle prepared as the high
dose for instillation gave a hydrodynamic particle/aggre-
gate diameter range of 18.06-102.2 nm for QD-NH2 and
25.55-243 nm for QD-COOH with median diameters
of ~29 nm and 50 nm, respectively. See Additional file 1
for percent distribution from DLS measurements. TEM
images appeared to confirmed DLS size measurements,
with particle/aggregates in PBS that consisted primarily of
1–5 QD for both samples, with a slightly greater percent-
age of larger aggregates in the QD-COOH sample.
Indices of lung injury were quantified in the recovered
acellular bronchoalveolar lavage (BAL) fluid (BALF) at
different time points after intratracheal instillation of dif-
ferent doses of the QD-NH2 and QD-COOH samples
(Figure 2). LDH and albumin were significantly elevated
after treatment with both QD samples at the 12.5 μg














Figure 1 QD characterization. TEM micrographs of carboxyl-functionalize quantum dots (QD-COOH) (A) and amine-functionalized quantum
dots (QD-NH2) (D). FESEM micrographs of QD-COOH (B) and QD-NH2 (E), including a high magnification FESEM image of QD-COOH (B: inset).
The corresponding elemental mappings of QD-COOH (C) and QD-NH2 (F) were analyzed using energy dispersive X-ray (EDX) analysis at 20 keV
(Cd, Cadmium; O, Oxygen; P, Phosphorous; S, Sulfur; Se, Selenium; Zn, Zinc).
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treatment at days 1 through 5 post-treatment, and from
the QD-COOH exposure at days 14. After treatment
with the 5.0 μg dose, the QD samples caused an increase
in both lung injury parameters, primarily at days 5, 7,
and 14 after treatment. Treatment with the lowest dose
(1.25 μg) did not result in significant lung injury com-
pared to vehicle control.
Inflammatory chemokines, MCP-1 and MIP-2, were
measured in the recovered acellular BALF at different time
points after intratracheal instillation of different doses of
the QD-NH2 and QD-COOH samples (Figure 3). At 1
day, MCP-1 levels were significantly increased compared
to the other groups after treatment with the 5.0 and 12.5
μg dose of the QD-COOH sample (Figure 3A). MCP-1
levels were significantly elevated after exposure to the 12.5
μg dose of both QD samples on days 5, 7, and 14 after
treatment. The elevation was significantly greater in the
QD-NH2 group when compared to the QD-COOH group
at days 5 and 7, and greater in the QD-COOH group at
day 14. A similar response was observed for 5.0 μg dose at
7 and 14 days, whereas no significant differences were ob-
served between the groups at any of the time points after
treatment with the 1.25 μg dose. MIP-2 concentrations
were elevated in all groups when compared to vehicle con-
trol at day 1 and for the 5.0 and 12.5 μg doses at days 7,
14, and 28 after treatment (Figure 3B). At the time points
after day 1, there was no significant difference in MIP-2
when comparing the 1.25 μg dose group and control.Increases in specific inflammatory chemokines after
treatment with the different QD samples correlated with
inflammatory cells recovered by BAL at different time
points after IT instillation (Figure 4). Elevations in lung
AM were first observed at 3 days after treatment with
5.0 and 12.5 μg of both QD samples (Figure 4A). The
number of AM recovered from the lungs peaked at 7
and 14 days and were significantly elevated at the
highest dose of the QD samples. At 28 days after treat-
ment, lung AM recruitment was still significantly ele-
vated in the 5 and 12.5 μg dose QD-COOH groups.
There was a significant increase in lung PMN in rats ex-
posed to the 12.5 μg dose of both QD samples through-
out the 28-day period with the peak response occurring
at 7 and 14 days after treatment (Figure 4B). There was
a greater number of PMN recovered from the lungs of
rats treated with the highest dose of QD-NH2 compared
to QD-COOH at 3 and 5 days, whereas inflammation
was greater after treatment with the QD-COOH sample
at 14 and 28 days. Both QD samples increased lung
PMN numbers at 7 and 14 days after treatment with the
5.0 μg dose. Pulmonary treatment with the lowest dose
(1.25 μg) had no effect on lung PMN number. Lympho-
cyte influx into the lung followed a similar pattern as
PMN infiltration (Figure 4C).
Histopathological evaluation was performed on lung
tissue from rats 1, 7, 14, and 28 days after treatment
with saline, QD-NH2, or QD-COOH. At 1 day post-
instillation, there was minimal to mild inflammation
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Figure 2 Lung injury in vivo. Indices of lung injury measured in the acellular BALF recovered from rats 1, 3, 5, 7, 14, and 28 days after
intratracheal-instillation with 1.25, 5.0, or 12.5 μg of QD-NH2 or QD-COOH: (A) Lactate dehydrogenase (LDH), an indicator of general cytotoxicity,
and (B) albumin, an indicator of damage to the air-blood barrier. * significantly different from all groups; + significantly different from saline,
1.25 μg, and 5.0 μg groups; # significantly different from saline and 1.25 μg groups; @ significantly different from saline, 1.25 μg groups, and
QD-NH2 at 5.0 μg; X significantly different from saline, 1.25 μg groups, and QD-COOH at 5.0 μg; ^ significantly different from saline (p<0.05).
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tiocytic and eosinophilic infiltration. A minimal level of
epithelial cell necrosis and hypertrophy was present in
the QD-NH2 group only (data not shown). This inflam-
mation persisted up through 28 days post-exposure,
peaking on days 7 and 14, and was slightly more pro-
nounced in the QD-COOH group at days 7, 14, and 28.
Alveolar septal thickening was present on days 14 and
28 (Figure 5B & C) in both groups, primarily due to in-
filtration of macrophages and granulocytes, and was par-
ticularly notable in the terminal bronchiolar region in
the QD-COOH group. On day 28 in the QD-COOHgroup, foamy macrophages were found in alveoli and
clustered around vessels (Figure 5D).
In the assessment of the biodistribution and clearance
of Cd after QD treatment, the initial amount of Cd de-
posited in the left lungs of rats treated with QD-COOH
(10.55 ± 1.4 μg) was approximately 20% more than that
of those treated with QD-NH2 (8.01 ± 0.87μg) (Figure 6).
Difference in distribution may likely be due to the route
of exposure as intratracheal instillation can lead to an
uneven distribution between left and right lung lobes;
however, there may also be differences in the amount of
Cd between the two forms of QD where there is slightly
Time Post-Exposure
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Figure 3 In vivo pulmonary inflammatory indices. Inflammatory chemokines, monocyte chemotactic protein (MCP)-1 (A) and macrophage
inflammatory protein (MIP)-2 (B), were measured in the acellular BALF recovered from rats 1, 3, 5, 7, 14, and 28 days after intratracheal-instillation
with 1.25, 5.0, or 12.5 μg of QD-NH2 or QD-COOH. * significantly different from all groups; + significantly different from saline, 1.25 μg, and 5.0 μg
groups; # significantly different from saline and 1.25 μg groups; @ significantly different from saline, 1.25 μg groups, and QD-NH2 at 5.0 μg; ~ significantly
different from 12.5 μg dose, 1.25 μg dose, and saline; ^ significantly different from saline (p<0.05).
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burden is approximately 13 μg on day 7. In addition, if it
is assumed that the left lung represents half the Cd bur-
den, there is approximately twice as much Cd in the
samples as reported by the manufacturer indicating the
actual high dose was closer to 20 μg rather than 12.5 μg,
and possibly higher in the COOH sample.
Relative to the initial amount deposited, rats exposed
to QD-COOH were able to clear more QD from the
lungs over time when compared to rats exposed to QD-
NH2; however, the majority of particles in both groups
persisted out to day 14 in the lungs. No Cd was mea-
sured above the limit of detection in the blood, brain,heart, liver, or spleen in either treatment group (data not
shown), either due to the lack of translocation or the
relatively small amount of Cd that may have translocated
relative to the overall organ weight due to the limit of
detection in rats exposed to QD-COOH, CD appeared
in the LALN and kidneys as early as day 7, and ~ 3-5% of
Cd instilled could be detected in the LALN while ~10-20%
was located in the kidney by day 14 (Figure 6A). By day 28,
increased clearance from the lungs and increased depo-
sition in LALN and kidneys was evident. The pattern of
clearance for rats exposed to QD-NH2 was similar; how-
ever, the time frame for clearance to the kidney and LALN
was slower. In rats treated with QD-NH2, ~20% of the
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Figure 4 (See legend on next page.)
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Figure 4 Cellular differentials in bronchoalveolar lavage. Total number of (A) alveolar macrophages (AM), (B) polymorphonuclear cells (PMN),
and (C) lymphocytes recovered by from rats 1, 3, 5, 7, 14, and 28 days after intratracheal-instillation with 1.25, 5.0, or 12.5 μg of QD-NH2 or QD-
COOH. * significantly different from all groups; + significantly different from saline, 1.25 μg, and 5.0 μg groups; # significantly different from saline
and 1.25 μg groups; @ significantly different from saline, 1.25 μg groups, and QD-NH2 at 5.0 μg; X significantly different from saline, 1.25 μg
groups, and QD-COOH at 5.0 μg; ^ significantly different from saline (p<0.05).
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Cd was detected in the LALN until day 28 (Figure 6B).
Fluorescent confocal microscopy was used to image
QD in lung cells recovered by BAL at different time
points after treatment (Figure 7). Particles were concen-
trated inside AM at 1 day after lung treatment with 12.5
μg of either the QD-NH2 (Figure 7B) or QD-COOH
(Figure 7C) sample and could be easily imaged up to 5
days post-exposure. This was also true for both QD sam-
ples at the 5.0 μg dose (data not shown). By day 28, very
little QD in AM could be imaged using confocal micros-
copy (Figure 7E & F), possibly due to clearance and/or
destabilization of the QD leading to decreased fluores-
cence. QD were not observed inside AM after instilla-
tion of the 1.25 μg dose (data not shown). PMN also
were observed to have engulfed QD at early time points
after treatment (Figure 7 inset, arrows).
At 1 day after treatment, vacuoles containing QD-
COOH or QD-NH2 were seen with high magnificationFigure 5 Histopathological evaluation of pulmonary injury and inflam
after intratracheal instillation with saline (A), QD-NH2 (B), or QD-COOH (C &
around a blood vessel and in alveoli are present, with minimal thickening o
alveolar walls are thickened (C, black arrows) and alveoli contain foamy ma
alveoli (D, yellow arrows). V, vessel.TEM in AM recovered from BAL (Figure 8). EDX spec-
tra confirmed that the vacuoles were positive for Cd, a
core QD element. At the later time points (days 7, 14,
and 28), it appeared that AM still contained QD; how-
ever, whether or not these vacuoles contain Cd, could
not be confirmed with EDX (data not shown). It was in-
teresting to note that AM from the rats treated with
QD-COOH or QD-NH2 at the later time points post-
treatment both contained “vacuoles” that had morpho-
logical structures that were not observed in AM from
control rats (data not shown). The content of these
crystal-like structures were not known.
Lung tissue sections showing AM in situ that had
phagocytized QDs were imaged by fluorescent confocal
microscopy at 2 hr and 1 day after treatment (Figure 9).
Numerous AM were observed to have engulfed QD
early after treatment. Dispersed QD were observed
throughout the alveolar region on the epithelium and in
the interstitium (arrows) as late as day 5 after treatment.mation. Micrographs of H&E-stained tissue sections from rats 28 days
D). At 28 days after instillation of QD-NH2, infiltration of leukocytes
f alveoli septa (B, black arrows). At 28 days in the QD-COOH group,
crophages, and hyperplastic Type II epithelial cells can be found in














































Figure 6 Neutron activation analysis of QD biodistribution following pulmonary exposure. Biodistribution of QD over time in rats
intratracheally-instilled with 12.5 μg of QD-COOH (A) or QD-NH2 (B) using neutron activation to quantify the amount of cadmium (Cd) per organ.
Organs measured were: left lung, lung-associated lymph nodes (LALN), blood, heart, liver, kidneys, brain, and spleen. No Cd was detected in the
blood, heart, liver, spleen, or brain.
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dent on the stability of the QD, an alternate imaging tech-
nique was employed to evaluate where particles persisted
as instability may have affected evaluation by confocal mi-
croscopy. Silver enhancement staining of QD in lung tis-
sue indicated that the QD in both treatment groups were
found along airway epithelium, concentrated in AM, and
deposited along the alveolar epithelium at 1 day after
treatment (Figure 10A-C). Slightly more QD were depos-
ited in the airways of rats treated with QD-NH2, whereas
parenchymal deposition of QD in rats treated with QD-
COOH was slightly greater. By day 14, QD were stillfound in AM, and, to a lesser degree, along the alveolar
epithelium in rats from both groups (Figure 10D & E).
QD were also found in bronchoalveolar lymphoid tissue
(Figure 10F). Concentrations of QD in rats exposed to
QD-COOH appeared to be located more in the inter-
stitium and around vessels (arrows), in addition to being
highly concentrated in AM. At 28 days after treatment,
the QD-COOH sample was still readily detectable by sil-
ver enhancement (Figure 11), whereas the QD-NH2 silver-
staining, although present, was not as intense (data not
shown) despite persistence of Cd as indicated in Figure 6B.
AM still contained a high concentration of QD- COOH,
A B C
D E F
Figure 7 Confocal evaluation of AM uptake of QD in vivo. Confocal micrographs (63x-zoomed or 100x objective) of AM from the BAL of rats
1 (A-C) and 28 (D-F) days after intratracheal instillation with 12.5 μg QD-NH2 or QD-COOH (red/yellow), or PBS (control): (A) control – 1 day post-
exposure, (B) QD-NH2 - 1 day post-exposure, (C) QD-COOH – 1 day post-exposure, (D) control – 28 days post-exposure, (E) QD-NH2 - 28 days
post-exposure, and (F) QD-COOH – 28 days post-exposure. AM are green and QD are yellow/red. PMN uptake of QD is shown in the smaller inset
micrograph in panel C (arrows).
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(Figure 11B & C), possibly in the process of being cleared
through the lymphatics from the lungs. A high magnifica-
tion image illustrates the accumulation of the QD in and
around a lymphatic vessel (Figure 11D).
Discussion
QD are being developed and used for a variety of appli-
cations (e.g., drug delivery, diagnostic procedures) that
may lead to human exposure in medical settings. In
addition, the number of workers producing or using
nanomaterials, such as QD, is growing substantially. Un-
fortunately, little information exists about the potential
health hazards associated with medical, environmental,
or occupational lung exposures to QD. One important
occupational health issue that is being addressed by the
National Institute for Occupational Safety and Health
(NIOSH) Nanotechnology Research Center is determin-
ing the toxic potential and fate of nanomaterials in the
body after exposure [13]. Therefore, there is interest in
assessing the potential adverse health outcomes thatmay occur following pulmonary QD exposure, and the
mechanisms underlying these responses. NIOSH is ac-
tively performing field studies to evaluate the potential
exposure of workers in the QD industry (personal com-
munication with Kenneth Martinez, 2012).
In vivo animal studies assessing the pulmonary re-
sponses after exposure to QD are limited. The QD sam-
ples examined in the current study were composed of a
CdSe core. Cd is a widespread environmental and occupa-
tional pollutant and has been classified as a type I carcino-
gen by the International Agency for Cancer Research
(IARC [14]). Inhalation of Cd-containing pollutants can
result in metal fume fever, chemical pneumonitis, pulmon-
ary edema, and pleural effusion [15]. In addition to com-
position and the presence of potentially toxic metals,
surface coating, charge, and size may influence QD tox-
icity. In vivo lung toxicology studies have shown that
nanoparticles of identical composition and mass may be
more toxic (Brown et al. [16,17]) when compared to
their larger counterparts. In vitro studies indicate that
Cd-containing QD with a smaller diameter had greater
A B
C D
Figure 8 AM uptake of QD visualized by transmission electron microscopy. TEM micrographs of AM recovered by BAL at 1 day after
intratracheal instillation with QD-COOH (A & B) or QD-NH2 (C & D) (12.5 μg/rat). High magnification TEMs of the area in the red box illustrate AM
vacuoles containing QD-COOH (B) and QD-NH2 (D).
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pared to a larger QD of the same composition that were
less cytotoxic and remained in the cell cytoplasm [18].
Functionality and surface charge of QD are also of import-
ant in regard to conjugation to other particles or mole-
cules for targeted delivery of substances in the body or
tracking of substances. The QD in the current study were
functionalized with different surface moieties by the
manufacturer to examine the effect of surface charge on
toxicity and were determined to be in the ultrafine size
range with core size diameters of 5–10 nm.
A significant increase in lung injury was observed at
different time points after a single intratracheal instilla-
tion of the QD-COOH and QD-NH2 samples in the
current study. Lung injury parameters, LDH and albu-
min, were significantly increased immediately after treat-
ment with the 12.5 μg dose, peaked at day 7 post-
exposure, and remained elevated throughout the 28 day
period, even though the response at 28 days wassubsiding. Evidence for lung injury was not apparent
until 5 days after treatment with the 5 μg dose of QD-
NH2 sample where it was found to be more potent than
the QD-COOH treatment. At 7 days post-exposure, the
5 μg dose of the QD-COOH sample began to exhibit
toxicity and was more potent than the QD-NH2 sample.
The difference in temporal response between the two
doses may be related to the lungs responding earlier to a
substantially greater number of particles at the higher
12.5 μg dose (e.g., dose effect), whereas the later injury
response after treatment with the 5.0 μg dose may better
reflect a potential mechanism of toxicity, the in situ dis-
solution of the QD by AM, leading to the direct expos-
ure of the lung cells to free Cd (e.g., chemical effect).
Moreover, the QD-NH2 sample induced significantly
more lung injury at earlier time points after treatment
compared to the QD-COOH, which may be due to a dif-
ference in particle distribution related to charge or a
















Figure 9 Confocal evaluation of tissue distribution of QD. Confocal micrographs of lungs (green) that have been cryo-preserved, sectioned, and
imaged at 63x, 2 hours (A-C) and 1 day (D-F) after intratracheal instillation with 12.5 μg of QD-NH2, QD-COOH, or PBS (control): (A) control – 2 hours
post-exposure, (B) QD-NH2 - 2 hours post-exposure, (C) QD-COOH – 2 hours post-exposure, (D) control – 1 day post-exposure, (E) QD-NH2 - 1 day
post-exposure, and (F) QD-COOH – 1 day post-exposure. Lung tissue auto-fluoresces green and QD are yellow/red. * indicates QD-containing AM,
white arrows indicate QD in tissue.
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combination of the two. Multiple studies have indicated
that coating affects destabilization of QD and that un-
coated Cd-containing QD released free Cd from the QD
core intracellularly and were cytotoxic in vitro [19,20].
In addition, Derfus et al. [21] demonstrated that the en-
capsulation of Cd/Se QD by a ZnS shell greatly reduced
both the amount of free Cd released and the production
of free radicals by QD.
In terms of lung inflammation as determined by the
number of PMN recovered from the lungs, a significant
inflammatory response was observed at 1 day after treat-
ment with the 12.5 μg dose, likely due to a dose/bolus ef-
fect because this initial response subsided by 3 days after
treatment, before increasing again and peaking at day 7. In
addition, the lower dose QD treatment groups had no ef-
fect on inflammation at 1, 3, and 5 days after treatment.
As was seen with the lung injury response, the number of
recovered lung PMN was significantly greater at earlier
time points (days 3 and 5) after treatment 12.5 μg
dose of QD-NH2 sample compared to the QD-COOHsample, whereas PMN influx was greater in the QD-
COOH-treated rats at days 14 and 28 when compared to
those treated with QD-NH2, again implicating a likely dif-
ference in the dissolution rate between the two QD
samples and the release of free Cd. Despite these differ-
ences, the pattern of inflammation is similar between QD
groups, with peak responses between 7–14 days after
treatment for the 5 and 12.5 μg dose groups for both QD
samples. In addition to PMN influx, AM infiltration
peaked at these two time points as well. In agreement
with the inflammatory response seen in the current
study, Ma-Hock et al. [10] also observed a transient local
PMN inflammation in the lungs of rats that was associated
with increases in inflammatory chemokines, MCP-1 and
MIP-2, after a short-term inhalation of Cd-containing QD
(cadmium sulfide core with a cadmium hydroxyl shell –
CdS/Cd(OH)2)). This delay in inflammatory cell influx
into the lungs after treatment is additional evidence that
free Cd released from the dissolution of the QD structure
is likely a causative factor responsible for the pulmonary




Figure 10 Autometallographic evaluation of tissue distribution of QD 1 and 14 days post-exposure. Silver enhancement staining of QD in
lung tissue of rats 1 (A-C) and 14 (E-F) days after intratracheal instillation with 12.5 μg of QD-NH2 or QD-COOH, or PBS (control). (A) Lung from a
control rat 1 day post-exposure showing no silver staining. (B) Silver enhancement of QD-COOH in the lung of a rat 1 day post-exposure. QD can
be seen distributed along alveolar epithelium and in AM. (C) QD-NH2 enhanced with silver in rat lung 1 day after instillation. Distribution of QD-
NH2 does not appear to differ drastically from QD-COOH 1 day post-exposure in terms of deposition in the alveolar region and in macrophages;
however, there does appear to be slightly more deposition in the airways as shown in panel C. QD can also be seen throughout the epithelium
of a terminal bronchiole (TB). By day 14, QD-NH2 (D) and QD-COOH (E) appear to be more concentrated in AM with a lesser amount in the
tissue. QD-COOH can still be found in the interstitium and around vessels (green arrows). Both forms of QD were observed in bronchoalveolar
lymphoid tissue (BALT). Silver enhancement of QD-COOH in BALT 14 days post-exposure is shown in panel F.
BA
C D
Figure 11 Autometallographic evaluation of tissue distribution of QD 28 days post-exposure. Silver enhancement staining of QD in lung
tissue of rats 28 days after intratracheal instillation 12.5 μg of QD-COOH (B-D) or PBS (control) (A): a high magnification micrograph of QD-COOH
showing AM clustered around vessels walls (B), a low magnification micrograph of a vessel with QD-COOH in and surrounding areas that may be
perivascular lymphatic vessels (C), and several serial sections from the boxed area of Panel C imaged and stacked together at high magnification
to illustrate accumulation of QD in and around a possible lymphatic vessel (D).
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with the response subsiding (even at the highest dose) by
28 days after treatment with both QD samples.
Regarding lung deposition and clearance, QD-COOH
and QD-NH2 were both rapidly phagocytized in vivo by
AM in a dose-dependent manner as early as 2 hr after
intratracheal instillation. Cd burden in LALN beginning
1 week after exposure suggests that at least a portion of
the QD in the alveolar region are cleared via scavenging
phagocytes which then migrate out of the lung through
the lymphatics. Ma-Hock et al. [10] also observed AM
clearance to the LALN as well. Translocation from the
lung and clearance via the blood is also a possible route
of clearance for particles in the lung. Confocal micros-
copy revealed some QD to have deposited on the epithe-
lium outside AM and move to the interstitium, giving
this portion of QD the potential of reaching the systemic
circulation and translocating to other organs. However,
measureable levels of Cd as determined by neutron acti-
vation did not appear in a systemic organ until 7 and 14
days after treatment with the QD-COOH and QD-NH2
samples, respectively. Using an in vitro model, Geys
et al. [22] examined the effect of surface charge on the
translocation of non-functionalized QD, QD-COOH,
and QD-NH2 through a tight monolayer of primary rat
alveolar epithelial cells. They observed that QD did not
translocate through the tight junctions of alveolar epi-
thelial cells, regardless of surface charge, without disrup-
tion of the cell-to-cell barrier induced by oxidative
stress. In the current study, Cd depositing in extra-
pulmonary organ systems corresponds to the time points
post-exposure where the greatest lung injury is observed,
rendering it likely that the translocation of QD is occur-
ring, and that this may be a passive process via “leaky”
cell junctions, rather than an active process.
Neutron activation showed that at day 1 there was more
Cd measured in the lungs of rats treated with QD-COOH
when compared to those treated with QD-NH2. Uneven
distribution due to route of administration (intratracheal
instillation resulting in more QD going to one bronchus
or the other), differences in deposition pattern (greater de-
position in upper airways versus parenchyma), or differ-
ences in destabilization and translocation of the particles
in the first 24 hours may contribute to this discrepancy.
Differences in the rate of clearance were evident with
greater percentage of QD cleared from the lungs by day
28 in the QD-COOH group compared to the QD-NH2
group, relative to early deposition amounts. However, the
pattern of clearance via the lymphatics, and translocation
to the kidneys via the blood stream, were similar between
the two QD, and neutron activation analysis showed that
Cd persisted in the lungs at least 28 days after exposure
for both QD. This data is in agreement with other stud-
ies. Using inductively coupled plasma optical emissionspectroscopy (ICP-OES) as opposed to neutron activation,
Ma-Hock et al. [10] also observed that Cd levels in the
lungs did not decline during a 3-week recovery period
after inhalation exposure to water soluble CdS/Cd(OH)2.
Silver enhancement staining of lung tissue recovered
from the QD-treated animals in the current study pro-
vided additional evidence that Cd persisted in the lungs at
28 days after treatment. The silver staining, used to image
deposited metal particles, taken into consideration with
the diminished fluorescent signal observed 1 week after
exposure to QD using confocal microscopy, is another
indication that free Cd had dissociated from the QD
beginning 5–7 days after treatment. Although both forms
of QD persisted in the lung up to 28 days, the rate of
clearance appears to differ between the positively and
negatively charged particles, with a slower clearance rate
observed for QD-NH2 particles. This difference in the
clearance patterns may be due to different dissolution
rates of Cd from the QD after AM phagocytosis and en-
zymatic digestion because of the different surface charges
and properties of the two QD samples as discussed above.
In addition, a greater influx of phagocytes was observed at
the later time points post-exposure to QD-COOH when
compared to QD-NH2, resulting in a greater capacity for
clearance. Also, it should be noted that initial Cd depos-
ition in the lungs was greater with the QD-COOH sample
compared to the QD-NH2 sample and this may contribute
to a greater initial clearance of QD-COOH. As mentioned
above, for both QD, a portion of the clearance appeared
to occur via mechanical clearance by AM, as well as by
extrapulmonary translocation.
The kidney, a primary target organ of Cd toxicity, was
the only extrapulmonary organ in which Cd was measured
in the current study. Relatively small concentrations of Cd
appeared in the kidneys at 7 days after QD-COOH treat-
ment and at 14 days after QD-NH2 treatment with levels
increasing at 28 days for both groups. Ma-Hock et al. [10]
also observed small amounts of Cd in kidney, which in-
creased very slightly over the post-exposure recovery
period. Importantly, histological analysis of kidney in their
study did not indicate any morphological abnormalities
after short-term QD inhalation. The Cd levels measured
in the kidney of the current study were substantially lower
than the levels of 104–252 μg/g wet kidney that were
observed to cause renal dysfunction in rats after oral Cd
treatment [23]. The presence of Cd in the kidney is in line
with the findings of Chen et al. [24] and Lin et al. [25]
who observed the accumulation of QD in the kidney of
rats and mice, respectively, after intravenous injection.
However, Ma-Hock et al. [10] measured Cd in the liver
after inhalation, and both Chen et al. [24] and Lin et al.
[25] observed QD in the liver after intravenous exposure.
Measureable levels of Cd were not detected in the liver
after intratracheal treatment of the different QD samples
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istration combined. In agreement with the Ma-Hock et al.
[10] study, lung treatment did not lead to the accumulation
of Cd in the brain or spleen in the current study.
Based on the findings of the current study and others,
several conclusions can be made concerning the toxicity
and fate of QD after pulmonary treatment. Lung expos-
ure to high enough concentrations of CdSe QD can
cause transient lung inflammation and injury that
appears to be related to the dissolution of the QD
structure and removal of the ZnS shell coating, allowing
for the release of free Cd. Different surface charges due
to the addition of different functional groups attached to
the surface of the QD may influence both the toxic pul-
monary response and the persistence and clearance of
the Cd from the lungs. QD-NH2 appeared to induce
more injury and inflammation at earlier time points
post-exposure where epithelial cell necrosis and type II
cell hyperplasia were minimal but present; whereas QD-
COOH cause greater injury and cellular influx at the
later time points post-exposure. Although differences
exist between the two particles, the pattern of toxicity
was primarily the same for both QD with toxicity
peaking at days 7 and 14 and beginning to subside over
time. This is in agreement with Clift et al. [11], who
found that QD with organic coatings were more toxic
than QD-COOH and QD-NH2(PEG) with only slightly
more toxicity present with the carboxyl groups versus
the amine groups. In addition, toxicity appears to be
dependent on the availability of free Cd for both QD, as
well, although dissolution rates may vary. Overall, des-
pite a relatively high pulmonary load, the systemic avail-
ability of the QD appears to be low. No free Cd was
measured in blood, brain, liver, and heart in the current
study. Measureable, but relatively small, amounts of free
Cd did accumulate in the kidney, the main storage organ
of Cd in the body.
Overall, both forms of QD induced lung damaged
which was more severe one week after exposure, with
QD-NH2 having induced more toxicity at the early time
points post-exposure and QD-COOH having been more
toxic at the later time points. However, the peak damage
for both QD is around day 7 and sustained until day 14.
This damage coincided with the lack of fluorescence in
lung tissue under confocal microscopy, which indicates
destabilization of the QD, and with evidence that Cd still
persisted in the lungs (silver staining of tissues) at the
times of peak lung damage. The data suggests that Cd
became bioavailable over time due to destabilization of
the QD in the lung, and induced injury as it became
available and while it persisted there. Althought the rate
of clearance of the QD-NH2 and QD-COOH differed,
indicating a potentially different destabilization rate, the
pattern of clearance over time was similar, primarily viathe lymphatics and translocation systemically to the
kidneys.
Methods
Quantum dots and characterization
Water-soluble quantum dots (Evident Technologies, Inc.,
Troy, NY) (QD), with a hydrodynamic diameter in the
range of 30–50 nm, were composed of a CdSe core with a
ZnS shell and had an emission peak of 620nm. The sur-
face of the QD particles was functionalized with either
carboxylic terminal groups (QD-COOH; stock = 2.1
nmol/ml water equivalent to 250 μg/ml) or amine ter-
minal groups (QD-NH2; stock = 3.4 nmol/ml water
equivalent to 250 μg/ml) by the manufacturer and were
supplied in water (no toluene present). Transmission
electron microscopy (TEM) was performed to detect indi-
vidual and agglomerated QD in suspension. QD were di-
luted in deionized water to a concentration of 2.5 μg/ml
and evaluated using a JEOL-1220 transmission electron
microscope (JEOL, Inc., Tokyo, Japan). In addition QD
suspended in PBS at a final instillate concentration were
also imaged. Field emission scanning electron microscopy
(FESEM) was used to obtain an energy dispersion X-ray
(EDX) to illustrate elemental composition. For FESEM,
QD were suspended in deionized water at a concentration
of 2.5 μg/ml, dried onto carbon planchets, and imaged
using a Hitachi Model S-4800 microscope (Hitachi High
Technologies America, Inc., Gaithersburg, MD) operated
between 5 and 20 kV. In addition, QD suspended in
phosphate-buffered saline (PBS) at the instillate concen-
tration for groups exposed to the high dose of particles
were also analyzed using a dynamic light scatterer (DLS;
Microtrac Inc., Largo, FL) to assess aggregation in the de-
livery vehicle. TEM of the instillate was also performed to
further analyze aggregation of particles.
Animals
Male Sprague–Dawley [Hla:(SD)CVF] rats (Hilltop Labora-
tories, Scottdale, PA) weighing 250–300 g, approximately
10 weeks old, were used for all experiments in accordance
with a protocol approved by the institute’s Animal Care
and Use Committee (ACUC). Animals were given a Teklad
2918 diet and tap water ad libitum, housed in a clean air
and viral- and antigen-free room with restricted access in
an Association for Assessment and Accreditation of La-
boratory Animal Care International (AAALAC)-approved
animal facility. All animals were allowed to acclimate for
one week before use. The rats were monitored and found
to be free of endogenous viral pathogens, parasites,
mycoplasms, Helicobacter, and CAR Bacillus.
In vivo exposure and study design
On day 0, male Sprague–Dawley rats were lightly anesthe-
tized by an intraperitoneal (i.p.) injection of 0.6 ml of a 1%
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apolis, IN), and intratracheal instillation (IT) was performed
with a volume of 300 μl of QD-NH2 or QD-COOH diluted
in PBS at doses of 12.5 μg, 5.0 μg, or 1.25 μg /rat. Vehicle
control rats received an equivalent volume (300 μl) of ster-
ile PBS by IT. Treated animals then were sacrificed with
an overdose of sodium pentobarbital (>100 mg/kg bwt;
Sleepaway, Fort Dodge Animal Health, Wyeth, Madison,
NJ) followed by exanguination at 1, 3, 5, 7, 14, or 28 days
after QD exposure. An additional 2 hour time point was
conducted with the 12.5 μg dose to evaluate lung tissue
for QD deposition and biodistribution. Bronchoalveolar
lavage (BAL) was performed on right lungs with one lobe
ligated for later microscopic preparation and analysis. To
assess lung damage, lactate dehydrogenase (LDH) and albu-
min levels were measured in the first fraction of acellular
BAL fluid (BALF). Recovered BAL cells were differentiated
to assess lung inflammation, as well as seeded onto glass
coverslips and fixed for laser scanning confocal microscopy
(LSCM) analysis. Additional aliquots of BAL cells were
suspended in Karnovsky’s fixative and imaged using TEM.
The ligated right lobe of rats treated with 12.5 μg of QD
was either: (1) inflated with a Tissue-Tek O.C.T. Com-
pound (Sakura Finetek Inc., Torrance, CA) + 20% su-
crose solution, cryo-preserved, and sectioned for LSCM
or (2) pressure inflated with 10% formalin, embedded,
sectioned, and stained for histological evaluation or
autometallographic silver enhancement. To assess bio-
distribution and clearance of QD, left lungs, lung-
associated lymph nodes (LALN), blood, brains, hearts,
kidneys, livers, and spleens were analyzed using neutron
activation.
BAL cell and fluid collection
BAL was performed by washing the lungs of treated rats
with aliquots of PBS in order to obtain pulmonary cells for
morphological and functional analysis. The acellular BALF
was retained for analysis of indicators of tissue damage
and cellular activity. Rats were euthanized with an i.p.
overdose of sodium pentobarbital (>100 mg/kg body
weight; Sleepaway, Fort Dodge Animal Health, Wyeth,
Madison, NJ), the trachea was cannulated, the chest cavity
was opened, the left lung was clamped off, one right lobe
was ligated, and BAL was performed on the right lung via
the tracheal cannula at different time points after IT. The
acellular fraction of the first BAL was obtained by filling
the right lung with 1 ml/100 g body weight of PBS, massa-
ging for 30 seconds, withdrawing, and repeating the
process one more time. This concentrated aliquot was
withdrawn, retained, kept separately, and was designated
as the first fraction of BALF. The following lavage aliquots
were 6 ml in volume, instilled once with light massaging,
withdrawn, and combined until a 30 ml volume was
obtained. For each animal, both fractions of BAL werecentrifuged, the cell pellets were combined and resus-
pended in 1ml of PBS, and the acellular fluid from the first
fraction was retained for further analysis.
Evaluation of lung injury and inflammation
LDH and albumin
The presence of albumin and LDH in the acellular BALF
of all treatment groups was measured to evaluate the loss
of integrity of the alveolar-capillary barrier and general
cytotoxicity, respectively. Measurements of both albumin
and LDH in the acellular fluid were obtained using a Cobas
Mira analyzer (Roche Diagnostic Systems, Montclair,
IN). Albumin was determined by spectrophotometric
measurement of the reaction product of albumin with
bromcresol green (628 nm) according to a method by
Sigma Diagnostics (St. Louis, MO). LDH activity was
quantified by detection of the oxidation of lactate coupled
to the reduction of NAD+ at a spectrophotometric setting
of 340 nm.
Inflammatory chemokines
Monocyte chemotactic protein (MCP)-1 and macro-
phage inflammatory protein (MIP)-2 were measured in
the acellular BALF of rats pre-treated with QD or PBS
using commercially available enzyme-linked immuno-
sorbent assay (ELISA) kits (BioSource International Inc.,
Camarillo, CA).
Cell differentials
Total BAL cells collected from rats treated with QD or PBS
were counted using a Coulter Multisizer II (Coulter Elec-
tronics, Hialeah, FL). Cell differentials were performed to
determine the total number of AM, polymorphonuclear
leukocytes (PMN), and lymphocytes. Briefly, 1 × 105 cells
from each rat were spun down onto slides with a Cytospin
3 centrifuge (Shandon Life Sciences International, Cheshire,
England) and labeled with Leukostat stain (Fisher Scientific,
Pittsburgh, PA) to differentiate cell types. Two hundred
cells per slide were counted, and the percentage of alveolar
macrophages (AM), polymorphonuclear cells (neutrophils,
PMN), and lymphocytes were multiplied by the total num-
ber of cells to calculate the total number of each cell type.
Histopathology
The formalin fixed right lobe from animals in each group
was embedded in paraffin, sectioned onto slides, and
stained with hematoxylin and eosin (H&E). H&E-stained
slides were qualitatively analyzed for indications of inflam-
mation and injury by a certified veterinary pathologist at
Charles River Laboratories (Wilmington, MA) who was
blinded to the treatment groups. Indices of inflammation
and injury were scored on scale of 0–5, where 0 = no
observed effect, 1 = minimal response, 2 = mild response,
4 = moderate response, and 5 = severe response.
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Neutron activation
Left lung, LALN, blood, brain, heart, kidney, liver, and
spleen tissue were collected from a set of animals from
each treatment group (n = 3–4). Tissues were freeze-dried
by lyophilization, weighed, and analyzed for Cd content by
North Carolina State University Nuclear Reactor Program,
Department of Nuclear Engineering (Raleigh, NC) using
neutron activation. Briefly, tissue samples and standards
were irradiated in a PULSTAR reactor rotating exposure
port for 12 MW-hr. Samples decayed for approximately
1 wk and were counted for 10 min each on a gamma spec-
troscopy system analyzing for Cd.Confocal microscopy
Cryo-preserved lung tissue was sectioned, and lung tissue
sections and BAL cells were imaged with a LSCM (Carl
Zeiss, Inc., Thornwood, NY). Tissue sections were scanned
at 63x with a 543nm laser and an LP585 filter to detect
the QD (red), and tissue autofluorescence was detected
with a 488nm laser (green). Cells were counter-stained
with CellTracker green (Invitrogen Corp., Carlsbad, CA)
and imaged with a 63x or 100x objective at similar laser
settings.Electron microscopy
BAL cells were preserved with Karnovsky’s fixative, post-
fixed in osmium tetroxide, and embedded in epoxy resin.
QD were imaged in AM using a JEOL 1220 transmission
electron microscope (JEOL, Inc., Tokyo, Japan) at 80 KV.Tissue autometallographic silver enhancement
For light microscope visualization of QD, paraffin-
embedded lung tissue sections were deparaffinized and
dehydrated. The tissue sections were then washed with
multiple changes of deionized water. Sections were devel-
oped with a silver enhancement kit according to the manu-
facturer’s instructions (Polysciences, Inc., Warrington, PA).
The reaction was terminated after 30 min of development
by washing in deionized water, and then the lung tissue
sections were lightly counter-stained with Sirius Red [26].Statistical analysis
Results are expressed as means ± standard error of mea-
surement (SE). Statistical analyses were carried out with
the SigmaStat 3.1 statistical program (Chicago, IL). The
significance of the interaction among different treatment
groups for the different parameters at each time point
was assessed using analysis of variance (ANOVA). The
significance of difference between individual groups was
analyzed using the Holm-Sidak method with the criter-
ion of significance set at p<0.05.Additional file
Additional file 1: Percent size distribution of QD particles/
aggregates measured by dynamic light scattering (DLS). DLS
measurements of the hydrodynamic diameter size distribution of the
high dose preparation of QD-COOH and QD-NH2 particles and
aggregates in PBS. Diameters ranged from 18.06-102.2 nm for QD-NH2
and 25.55-243 nm for QD-COOH, with median diameters of
approximately 29 nm and 50 nm, respectively.
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